These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6252625)

  • 21. Estrogen replacement therapy at menopause. How benefits outweigh risks.
    Griffing GT; Allen SH
    Postgrad Med; 1994 Oct; 96(5):131-40. PubMed ID: 7937412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of clinical susceptibility bias in case-control studies. Analysis as illustrated by the menopausal syndrome and the risk of endometrial cancer.
    Horwitz RI; Feinstein AR
    Arch Intern Med; 1979 Oct; 139(10):1111-3. PubMed ID: 485742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Options for hormone therapy in women who have had a hysterectomy.
    Haney AF; Wild RA
    Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Links between hormone replacement therapy and neoplasia.
    Hulka BS
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genitourinary symptoms in the menopausal transition.
    Van Voorhis BJ
    Am J Med; 2005 Dec; 118 Suppl 12B():47-53. PubMed ID: 16414326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous estrogens and other factors in the epidemiology of breast cancer.
    Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C
    J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
    Col NF; Chlebowski RT
    Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estrogen therapy for the climateric and thromboembolic risk].
    Campagnoli C; Prelato L; Rossetti MG
    Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer risk under hormone therapy].
    Lauritzen C
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopause: evidence-based practice.
    Blake J
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):799-839. PubMed ID: 17084674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peroral treatment with natural human estrogens in the climacteric].
    Sele V; Obel E
    Ugeskr Laeger; 1980 Sep; 142(38):2497-500. PubMed ID: 7445154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous estrogens and development of breast and endometrial cancer.
    Vakil DV; Morgan RW; Halliday M
    Cancer Detect Prev; 1983; 6(4-5):415-24. PubMed ID: 6652636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.